JW.A News Alert John Wiley Sons Cl A (JW.A) 62.34 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
John Wiley Sons Cl A (JW.A) 62.34 $JW.A

My Take On Winners And Losers From President Obama's Free Community College Proposal
Aaron Barton - at Seeking Alpha - Mon Jan 12, 7:35AM CST

ESI: 7.58 (-0.29), PSO: 20.99 (-0.20), DV: 36.69 (+0.04), JW.A: 62.34 (+0.52), APOL: 25.97 (+0.33), HMHC: 19.98 (-0.09)

Update: John Wiley & Sons Earnings
Bram de Haas - at Seeking Alpha - Thu Dec 11, 12:02PM CST

JW.A: 62.34 (+0.52)

John Wiley Beats Q2 Earnings on Acquisitions, Restructuring - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 10:33AM CST
John Wiley & Sons Inc. (JW.A) reported second-quarter fiscal 2015 adjusted earnings per share of 90 cents that topped the Zacks Consensus Estimate by a couple of cents while rising 7% year over year.
SCHL: 37.06 (+0.31), ENL: 50.46 (-0.66), NYT: 14.45 (+0.28), JW.A: 62.34 (+0.52)

John Wiley & Sons' (JW.A) CEO Steve Smith on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Dec 09, 12:20PM CST

JW.A: 62.34 (+0.52)

John Wiley & Sons posts 2Q profit
Automated Insights - Tue Dec 09, 7:10AM CST
HOBOKEN, N.J. (AP) _ John Wiley & Sons Inc. (JW.A) on Tuesday reported net income of $53.8 million, or 90 cents per share, in its fiscal second quarter.
JW.B: 62.20 (+0.93), JW.A: 62.34 (+0.52)

John Wiley & Sons EPS of $0.90
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 7:06AM CST

JW.A: 62.34 (+0.52)

Notable earnings before Tuesday's open
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 4:30PM CST

PTRY: 36.72 (+0.05), UTIW: 12.10 (+0.25), SAIC: 52.99 (-0.23), AZO: 618.50 (+0.99), HDS: 28.62 (+0.24), CONN: 24.69 (-0.07), JW.A: 62.34 (+0.52), BURL: 51.91 (-0.56)

Comparing America's 3 Largest Book Publishing Companies
Joseph Cafariello - at Seeking Alpha - Fri Dec 05, 4:42PM CST

SCHL: 37.06 (+0.31), JW.A: 62.34 (+0.52), CRRC: 22.96 (+0.22)

Will John Wiley (JW.A) Miss Q2 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 4:41PM CST
Our proven model does not conclusively project John Wiley & Sons Inc. (JW-A) as likely to beat earnings this quarter.
NKE: 92.04 (+0.04), COST: 147.10 (-0.66), JW.A: 62.34 (+0.52), CASY: 88.93 (-1.10)

Will John Wiley Gain from Transition to Digital Media? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 11:20AM CDT
John Wiley & Sons (JW.A) is transitioning to digitization due to soft demand for print media and recent acquisitions have a vital role to play in this. Inorganic expansion is being pursued aggressively at John Wiley and is yielding positive results as evident from the company???s first quarter fiscal 2015 results.
SCHL: 37.06 (+0.31), ENL: 50.46 (-0.66), SSP: 20.91 (+0.47), JW.A: 62.34 (+0.52)

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Monday: JW.A, HCC, RJF
at The Street - Fri Sep 26, 9:05AM CDT
JW.A HCC RJF are going ex-dividend Monday, Monday, September 29, 2014
RJF: 57.05 (-0.36), JW.A: 62.34 (+0.52), HCC: 55.48 (-0.06)

John Wiley Beats Q1 Earnings on Strategic Acquisitions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:00AM CDT
John Wiley & Sons Inc. (JW-A) reported first-quarter fiscal 2015 adjusted earnings per share of 56 cents that topped the Zacks Consensus Estimate while rising 10% year over year driven by acquisitions.
SCHL: 37.06 (+0.31), ENL: 50.46 (-0.66), JW.A: 62.34 (+0.52)

Will John Wiley (JW-A) Miss Q1 Earnings on Rising Costs? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 11:50AM CDT
Our proven model does not conclusively project John Wiley & Sons Inc. (JW-A) as likely to beat earnings this quarter.
LMNR: 20.30 (+0.07), MANU: 17.20 (-0.21), CVGW: 41.64 (+0.19), JW.A: 62.34 (+0.52)

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: JW.A, CUBE, RJF
at The Street - Thu Jun 26, 9:00AM CDT
JW.A CUBE RJF are going ex-dividend tomorrow, Friday, June 27, 2014, 4:00 AM ET
RJF: 57.05 (-0.36), CUBE: 24.28 (-0.32), JW.A: 62.34 (+0.52)

John Wiley on Track to Achieve Targeted Cost Reductions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 10:30AM CDT
We initiated a research report on John Wiley & Sons Inc. (JW-A).
SCHL: 37.06 (+0.31), ENL: 50.46 (-0.66), SSP: 20.91 (+0.47), JW.A: 62.34 (+0.52)

John Wiley Shares Up on Robust Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 9:25AM CDT
Shares of John Wiley & Sons Inc. (JW-A) gained nearly 6% on the index yesterday following better-than-expected fourth quarter fiscal 2014 results.
SCHL: 37.06 (+0.31), ENL: 50.46 (-0.66), SSP: 20.91 (+0.47), JW.A: 62.34 (+0.52)

How Will John Wiley & Sons (JW.A) Stock Be Affected By Its Fourth Quarter Earnings Results?
at The Street - Tue Jun 17, 8:25AM CDT
John Wiley & Sons (JW.A) reported fourth quarter earnings ahead of analysts forecasts on Tuesday.
JW.A: 62.34 (+0.52)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting Plans for the 2024 Carter Work Project Unleashed

Updated Category News Views 338

Exciting Plans for the Upcoming Jimmy & Rosalynn Carter Work Project Twin Cities Habitat for Humanity is set to launch the 2024 Jimmy & Rosalynn Carter Work Project, an incredible weeklong homebuilding event. This initiative is sure to foster a great sense of community spirit, with notable hosts such as Garth Brooks and Trisha Yearwood. With over 4,000 volunteers...

Continue Reading
Market Veep Achieves Recognition for Stellar Growth in Marketing

Updated Category News Views 175

Market Veep Celebrates Recognition for Outstanding Growth Market Veep is thrilled to share its latest achievement, having earned a spot on the prestigious Inc. Northeast Regionals List for 2025. This recognition is a testament to the agency's remarkable growth and significant contributions to its clients, highlighting its innovative strategies and unwavering dedication in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 135

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading
Leadership Transformations at United Group: Insightful Changes Ahead

Updated Category News Views 537

New Leadership Direction at United Group United Group has recently undergone significant leadership changes aimed at refining its business strategy focused on EU markets. The organization has officially appointed Stan Miller as CEO. Alongside him, Libor Voncina has taken the role of Deputy CEO. This transition signifies a strategic overhaul for United Group after the...

Continue Reading
CECO Environmental Prepares for Earnings Call and Financial Report

Updated Category News Views 34

CECO Environmental Earnings Announcement Coming Soon CECO Environmental Corp. (Nasdaq: CECO), a prominent company focused on environmental solutions, has announced its upcoming third quarter financial results. As a leader in the industrial market, CECO strives to protect not only the environment but also the health of people and equipment worldwide. The eagerly...

Continue Reading